The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
Authors:
Open Access
- 29 January 2024
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 212, S64-S76
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
This publication has 85 references indexed in Scilit:
- Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complicationsAmerican Heart Journal, 2013
- Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic CardiomyopathyCirculation: Heart Failure, 2012
- Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2010
- Sudden Deaths in Young Competitive AthletesCirculation, 2009
- Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathyHeart, 2007
- Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening ProgramJAMA, 2006
- Lessons From the Failure and Recall of an Implantable Cardioverter-DefibrillatorCirculation, 2005
- Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathyThe American Journal of Cardiology, 2004
- Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2000
- Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden deathJACC, 1987